Literature DB >> 7350176

The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man.

D S Schade, R P Eaton.   

Abstract

Stress-induced diabetic ketoacidosis is characterized by an elevation in stress hormone concentration. Whether metabolic decompensation induces or results from the secretion of stress hormones has not been examined. Our study examined the temporal relationship between the onset of stress (pyrogen-induced shaking chills and fever); the elevation in stress hormone concentation; and the rise in plasma glucose, ketone bodies, and nonesterified fatty acid concentration. Insulin deficiency, which may itself induce stress hormone secretion, was prevented by the continuous infusion of insulin (0.01 U/kg.h). Pyrogen administration induced malaise and fever in all diabetic volunteers and the rapid endogenous secretion of all stress hormones. The rise in plasma GH, catecholamines, and cortisol preceded the rise in plasma nonesterified fatty acid and ketone body concentrations by at least 30 min. The rise in plasma glucagon concentration preceded the rise in plasma glucose concentration by at lease 1 h. Thus, these studies support a primary role for stress hormones in initiating metabolic decompensation in stressed diabetic man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350176     DOI: 10.1210/jcem-50-1-131

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Emotional stress and diabetic control: a postulated model for the effect of emotional distress upon intermediary metabolism in the diabetic.

Authors:  M B Evans
Journal:  Biofeedback Self Regul       Date:  1985-09

Review 2.  Management of Hyperglycemia and Diabetes in the Emergency Department.

Authors:  Justin B Echouffo-Tcheugui; Rajesh Garg
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

3.  Diabetic control in children and adolescents: Psychosocial factors and therapeutic efficacy.

Authors:  P Barglow; D V Edidin; A S Budlong-Springer; D Berndt; R Phillips; E Dubow
Journal:  J Youth Adolesc       Date:  1983-04

4.  Misleading Presentation of Euglycemic Diabetic Ketoacidosis: Implication for Low-Mid-Income Communities.

Authors:  Ezekiel Uba Nwose; Phillip Taderera Bwititi
Journal:  N Am J Med Sci       Date:  2015-11

5.  Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?

Authors:  Abbas E Kitabchi; Mary Beth Murphy; Judy Spencer; Robert Matteri; Jim Karas
Journal:  Diabetes Care       Date:  2008-08-11       Impact factor: 17.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.